Long-Term Outcomes of Immunosuppressive Therapy for Aplastic Anemia: A Single-Center Experience
Background. Bone marrow transplantation-ineligible aplastic anemia (AA) is most effectively treated with combined immunosuppressive therapy (IST). It yields remissions in most patients. However, it has such disadvantages as frequent relapses, incomplete hematologic recovery, and clonal evolution ris...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
Practical Medicine Publishing House
2023-06-01
|
| Series: | Клиническая онкогематология |
| Assuntos: | |
| Acceso en liña: | https://bloodjournal.ru/index.php/coh/article/view/40 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|